InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the detailed record of transactions filed by Richard Stephen, 董事. Insider active across 2 companies, notably Anika Therapeutics, Inc.. Aggregated, 6 reports have been recorded. Activity tracked since 16 June 2021. The latest transaction was disclosed on 20 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Richard Stephen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
10,402 股Common StockSEC:0001193125-26-279541:0
14,164 股0Common StockSEC:0001171843-25-004071:0
5,771 股0Common StockSEC:0001171843-24-003909:0
6,500 股0Common StockSEC:0001171843-23-003961:0
7,954 股0Common StockSEC:0001171843-22-004301:0
4,172 股0Common StockSEC:0001171843-21-004429:0
6 条申报中的 6 条
About Richard Stephen
Richard Stephen is a Board Member at Anika Therapeutics, Inc. He brings valuable experience in the biopharmaceutical sector, contributing to the strategic direction of the company. His role includes overseeing operations and commitment to best governance practices.
